Evidence map›Paper›PMID 37920691›Full record

ArticleRadiology case reports2024

Multimodality imaging approach in a case of vascular toxicity caused by cabozantinib.

Georgios Benetos, Angeliki Vakka, Vasiliki Kalogera, Eirini Solomou, Lefki Nikolopoulou, Vasiliki Katsi, Maria Drakopoulou, Constantinos Tsioufis, Konstantinos Toutouzas

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Georgios BenetosFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Angeliki VakkaThird Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Greece.
Vasiliki KalogeraFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Eirini SolomouFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Lefki NikolopoulouFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Vasiliki KatsiCardiology Department, Hippokration Hospital, Athens, Greece.
Maria DrakopoulouFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Constantinos TsioufisFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Konstantinos ToutouzasFirst Department of Cardiology, Hippokration Hospital, National & Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GRGeneral Hospital of Nikea · GRHippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular toxicity caused by cancer treatment can present as vasospasm, arterial thrombosis, and accelerated atherosclerosis. We report a case of a 60-year-old man with metastatic renal cell carcinoma under cabozantinib treatment for 3 years who presented to the hospital with relapsing episodes of rest angina. Due to the presence of ST depression in the 12-lead electrocardiogram and elevated troponin, a non-ST-segment elevation myocardial infarction was suspected. The patient underwent invasive coronary angiography, which revealed extended coronary artery spasm, and it subsided totally after nitrate administration. One year later, the patient presented again at the cardio-oncology outpatient clinic, reporting relapsing episodes of angina during the previous month. Coronary computed tomography angiography was performed, and it revealed 2 subsequent 70%-99% stenosis in OM1. To our knowledge, this is the first case of a patient treated with cabozantinib presenting with coronary artery spasm and accelerated atherosclerosis, in which a multimodality imaging approach was followed.

Indexed as

Accelerated atherosclerosisCabozantinibCoronary artery spasmMultimodality imaging approachVascular toxicity

Identifiers

PMID37920691
PMCPMC10618221
OpenAlexW4387853246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.